Carter's (CRI) Tops Q3 EPS by 29c, provides outlook

Carter's (NYSE: CRI) reported Q3 EPS of $1.84, $0.29 better than the analyst estimate of $1.55. Revenue for the quarter came in at $792 million versus the consensus estimate of $785.85 million.

Full year fiscal 2023 outlook

Net sales of $2.950 billion to $2.965 billion
Adjusted operating income of $325 million to $335 million
Adjusted diluted EPS of $5.95 to $6.15 versus the consensus of $5.89.
Operating cash flow of over $350 million

For earnings history and earnings-related data on Carter's (CRI) click here.

You May Also Be Interested In

• BMO Capital Starts Carter's (CRI) at Outperform
• BMO Capital Downgrades Westlake Chemical (WLK) to Market Perform
• Morgan Stanley Upgrades Lineage Inc (LINE) to Overweight